A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
for
Chronic Kidney Disease
Location: Chicago IL, Saint Paul MN, San Antonio TX, Glendale CA
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07024823
Phase 1, Recruiting
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
for
Gastroesophageal Adenocarcinoma
Location: Montreal, Newark DE, Washington D.C. DC, Pittsburgh PA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07069712
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
for
ATTR Amyloidosis
Location: Calgary
Sponsor: AstraZeneca
Sex: All
Age: 0+
Code: NCT06355934
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
for
Healthy Participants, Dyslipidemia
Location: Brooklyn MD, Port Orange FL, Jacksonville FL,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70
Code: NCT06980428
Phase 1, Recruiting
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
for
Multiple Myeloma
Location: New York NY, Charlottesville VA, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07073547
Phase 1, Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
for
Systemic Lupus Erythematosus
Location: New Hyde Park NY, Valhalla NY, The Bronx NY,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 17
Code: NCT05835310
Phase 3, Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
for
Melanoma, Non-small Cell Lung Cancer,
Location: Fairfax VA, Pittsburgh PA, Grand Rapids MI, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07115043
Phase 1, Phase 2, Recruiting
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
for
Lung Neoplasms
Location: Toronto, Calgary
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07143110
Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
for
Breast Cancer, Early Breast Cancer
Location: Winston-Salem NC, Irving TX, Aberdeen SD, Pierre SD
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05774951
Phase 3, Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Boston MA, Stony Brook NY, Mineola NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase 3, Recruiting
Observational Study Protocol: LIVER-R
for
Hepatobiliary Cancers
Location: Halifax, Boston MA, White Plains NY, Philadelphia PA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06252753
Recruiting
A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumors That Are MTAP Deficient
Location: Providence RI, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06130553
Phase 1, Phase 2, Recruiting
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Montreal, Baltimore MD, Fairfax VA, Houston TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT04686305
Phase 1, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: North Dartmouth MA, Quebec, Toms River NJ,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: New Britain CT, The Bronx NY, Staten Island NY,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06878261
Phase 3, Recruiting
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
for
Eosinophilic Granulomatosis With Polyangiitis (EGPA),
Location: Toronto, Highland Hills OH, Cincinnati OH, Aurora CO
Sponsor: AstraZeneca
Sex: All
Age: 6 - 17
Code: NCT06512883
Phase 3, Recruiting
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
for
Endometrial Cancer, Gastric Cancer,
Location: Commack NY, East Brunswick NJ, Columbus OH,